Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts

Tamas Kriska, Cody Cepura, Lawan Siangjong, Tina C. Wan, John A. Auchampach, Aviv Shaish, Dror Haratz, Ganesh Kumar, J R Falck, Kathryn M. Gauthier, William B. Campbell

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Lipoxygenases regulate vascular function by metabolizing arachidonic acid (AA) to dilator eicosanoids. Previously, we showed that endothelium-targeted adenoviral vector-mediated gene transfer of the human 15-lipoxygenase-1 (h15-LO-1) enhances arterial relaxation through the production of vasodilatory hydroxyepoxyeicosatrienoic acid (HEETA) and trihydroxyeicosatrienoic acid (THETA) metabolites. To further define this function, a transgenic (Tg) mouse line that overexpresses h15-LO-1 was studied. Western blot, immunohistochemistry and RT-PCR results confirmed expression of 15-LO-1 transgene in tissues, especially high quantity in coronary arterial wall, of Tg mice. Reverse-phase HPLC analysis of [14C]-AA metabolites in heart tissues revealed enhanced 15-HETE synthesis in Tg vs. WT mice. Among the 15-LO-1 metabolites, 15-HETE, erythro-13-H-14,15-EETA, and 11(R),12(S),15(S)-THETA relaxed the mouse mesenteric arteries to the greatest extent. The presence of h15-LO-1 increased acetylcholine- and AA-mediated relaxation in mesenteric arteries of Tg mice compared to WT mice. 15-LO-1 was most abundant in the heart; therefore, we used the Langendorff heart model to test the hypothesis that elevated 15-LO-1 levels would increase coronary flow following a short ischemia episode. Both peak flow and excess flow of reperfused hearts were significantly elevated in hearts from Tg compared to WT mice being 2.03 and 3.22 times greater, respectively. These results indicate that h15-LO-1-derived metabolites are highly vasoactive and may play a critical role in regulating coronary blood flow.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalProstaglandins and Other Lipid Mediators
Volume106
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Arachidonate 15-Lipoxygenase
Mesenteric Arteries
Lipoxygenase
Metabolites
Blood Vessels
Arachidonic Acid
Transgenic Mice
Acids
Lipoxygenases
Tissue
Gene transfer
Eicosanoids
Transgenes
Acetylcholine
Endothelium
Blood
Ischemia
Western Blotting
Immunohistochemistry
High Pressure Liquid Chromatography

Keywords

  • 15-Lipoxygenase
  • Coronary flow
  • Eicosanoids
  • Endothelium-derived hyperpolarizing factor
  • Ischemia/ reperfusion
  • Reactive hyperemia
  • Vasodilation

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts. / Kriska, Tamas; Cepura, Cody; Siangjong, Lawan; Wan, Tina C.; Auchampach, John A.; Shaish, Aviv; Haratz, Dror; Kumar, Ganesh; Falck, J R; Gauthier, Kathryn M.; Campbell, William B.

In: Prostaglandins and Other Lipid Mediators, Vol. 106, No. 1, 2013, p. 8-15.

Research output: Contribution to journalArticle

Kriska, T, Cepura, C, Siangjong, L, Wan, TC, Auchampach, JA, Shaish, A, Haratz, D, Kumar, G, Falck, JR, Gauthier, KM & Campbell, WB 2013, 'Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts', Prostaglandins and Other Lipid Mediators, vol. 106, no. 1, pp. 8-15. https://doi.org/10.1016/j.prostaglandins.2013.07.002
Kriska, Tamas ; Cepura, Cody ; Siangjong, Lawan ; Wan, Tina C. ; Auchampach, John A. ; Shaish, Aviv ; Haratz, Dror ; Kumar, Ganesh ; Falck, J R ; Gauthier, Kathryn M. ; Campbell, William B. / Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts. In: Prostaglandins and Other Lipid Mediators. 2013 ; Vol. 106, No. 1. pp. 8-15.
@article{3ac173438b6f47d1be71df9f6f0f2a72,
title = "Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts",
abstract = "Lipoxygenases regulate vascular function by metabolizing arachidonic acid (AA) to dilator eicosanoids. Previously, we showed that endothelium-targeted adenoviral vector-mediated gene transfer of the human 15-lipoxygenase-1 (h15-LO-1) enhances arterial relaxation through the production of vasodilatory hydroxyepoxyeicosatrienoic acid (HEETA) and trihydroxyeicosatrienoic acid (THETA) metabolites. To further define this function, a transgenic (Tg) mouse line that overexpresses h15-LO-1 was studied. Western blot, immunohistochemistry and RT-PCR results confirmed expression of 15-LO-1 transgene in tissues, especially high quantity in coronary arterial wall, of Tg mice. Reverse-phase HPLC analysis of [14C]-AA metabolites in heart tissues revealed enhanced 15-HETE synthesis in Tg vs. WT mice. Among the 15-LO-1 metabolites, 15-HETE, erythro-13-H-14,15-EETA, and 11(R),12(S),15(S)-THETA relaxed the mouse mesenteric arteries to the greatest extent. The presence of h15-LO-1 increased acetylcholine- and AA-mediated relaxation in mesenteric arteries of Tg mice compared to WT mice. 15-LO-1 was most abundant in the heart; therefore, we used the Langendorff heart model to test the hypothesis that elevated 15-LO-1 levels would increase coronary flow following a short ischemia episode. Both peak flow and excess flow of reperfused hearts were significantly elevated in hearts from Tg compared to WT mice being 2.03 and 3.22 times greater, respectively. These results indicate that h15-LO-1-derived metabolites are highly vasoactive and may play a critical role in regulating coronary blood flow.",
keywords = "15-Lipoxygenase, Coronary flow, Eicosanoids, Endothelium-derived hyperpolarizing factor, Ischemia/ reperfusion, Reactive hyperemia, Vasodilation",
author = "Tamas Kriska and Cody Cepura and Lawan Siangjong and Wan, {Tina C.} and Auchampach, {John A.} and Aviv Shaish and Dror Haratz and Ganesh Kumar and Falck, {J R} and Gauthier, {Kathryn M.} and Campbell, {William B.}",
year = "2013",
doi = "10.1016/j.prostaglandins.2013.07.002",
language = "English (US)",
volume = "106",
pages = "8--15",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts

AU - Kriska, Tamas

AU - Cepura, Cody

AU - Siangjong, Lawan

AU - Wan, Tina C.

AU - Auchampach, John A.

AU - Shaish, Aviv

AU - Haratz, Dror

AU - Kumar, Ganesh

AU - Falck, J R

AU - Gauthier, Kathryn M.

AU - Campbell, William B.

PY - 2013

Y1 - 2013

N2 - Lipoxygenases regulate vascular function by metabolizing arachidonic acid (AA) to dilator eicosanoids. Previously, we showed that endothelium-targeted adenoviral vector-mediated gene transfer of the human 15-lipoxygenase-1 (h15-LO-1) enhances arterial relaxation through the production of vasodilatory hydroxyepoxyeicosatrienoic acid (HEETA) and trihydroxyeicosatrienoic acid (THETA) metabolites. To further define this function, a transgenic (Tg) mouse line that overexpresses h15-LO-1 was studied. Western blot, immunohistochemistry and RT-PCR results confirmed expression of 15-LO-1 transgene in tissues, especially high quantity in coronary arterial wall, of Tg mice. Reverse-phase HPLC analysis of [14C]-AA metabolites in heart tissues revealed enhanced 15-HETE synthesis in Tg vs. WT mice. Among the 15-LO-1 metabolites, 15-HETE, erythro-13-H-14,15-EETA, and 11(R),12(S),15(S)-THETA relaxed the mouse mesenteric arteries to the greatest extent. The presence of h15-LO-1 increased acetylcholine- and AA-mediated relaxation in mesenteric arteries of Tg mice compared to WT mice. 15-LO-1 was most abundant in the heart; therefore, we used the Langendorff heart model to test the hypothesis that elevated 15-LO-1 levels would increase coronary flow following a short ischemia episode. Both peak flow and excess flow of reperfused hearts were significantly elevated in hearts from Tg compared to WT mice being 2.03 and 3.22 times greater, respectively. These results indicate that h15-LO-1-derived metabolites are highly vasoactive and may play a critical role in regulating coronary blood flow.

AB - Lipoxygenases regulate vascular function by metabolizing arachidonic acid (AA) to dilator eicosanoids. Previously, we showed that endothelium-targeted adenoviral vector-mediated gene transfer of the human 15-lipoxygenase-1 (h15-LO-1) enhances arterial relaxation through the production of vasodilatory hydroxyepoxyeicosatrienoic acid (HEETA) and trihydroxyeicosatrienoic acid (THETA) metabolites. To further define this function, a transgenic (Tg) mouse line that overexpresses h15-LO-1 was studied. Western blot, immunohistochemistry and RT-PCR results confirmed expression of 15-LO-1 transgene in tissues, especially high quantity in coronary arterial wall, of Tg mice. Reverse-phase HPLC analysis of [14C]-AA metabolites in heart tissues revealed enhanced 15-HETE synthesis in Tg vs. WT mice. Among the 15-LO-1 metabolites, 15-HETE, erythro-13-H-14,15-EETA, and 11(R),12(S),15(S)-THETA relaxed the mouse mesenteric arteries to the greatest extent. The presence of h15-LO-1 increased acetylcholine- and AA-mediated relaxation in mesenteric arteries of Tg mice compared to WT mice. 15-LO-1 was most abundant in the heart; therefore, we used the Langendorff heart model to test the hypothesis that elevated 15-LO-1 levels would increase coronary flow following a short ischemia episode. Both peak flow and excess flow of reperfused hearts were significantly elevated in hearts from Tg compared to WT mice being 2.03 and 3.22 times greater, respectively. These results indicate that h15-LO-1-derived metabolites are highly vasoactive and may play a critical role in regulating coronary blood flow.

KW - 15-Lipoxygenase

KW - Coronary flow

KW - Eicosanoids

KW - Endothelium-derived hyperpolarizing factor

KW - Ischemia/ reperfusion

KW - Reactive hyperemia

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=84883361018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883361018&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2013.07.002

DO - 10.1016/j.prostaglandins.2013.07.002

M3 - Article

C2 - 23872364

AN - SCOPUS:84883361018

VL - 106

SP - 8

EP - 15

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 1

ER -